Editors

EDITOR-IN-CHIEF

Gregory Daniel, PhD, MPH, RPh
Edwards Lifesciences, Washington DC, USA

EDITOR EMERITUS

J. Rick Turner, PhD, DSc
DRT Strategies, Inc, USA

ASSOCIATE EDITORS

Jonca Bull, MD
Strategic Regulatory Consultants, Washington, DC, USA

Iraj Daizadeh, PhD MBA
Takeda Pharmaceuticals USA, Inc., USA

Richard Day, MD, FRACP
St. Vincent's Hospital, Sydney, NSW, Australia

Kevin Haynes, PharmD
Healthcore, Inc., Philadelphia, PA, USA

Lisa Kammerman, PhD
Kammerman Consulting, Chevy Chase, MD, USA

Grazyna (Gracie) Lieberman
Genentech, San Francisco, CA, USA

Nicole Mahoney, PhD
Flatiron Health, New York, NY, USA

Munish Mehra, PhD
Tigermed, Gaithersburg, MD, USA

Richard C. Zink, PhD
Target PharmaSolutions, Chapel Hill, NC, US

SENIOR MANAGING EDITOR

Ranjini Prithviraj, PhD
DIA

EDITORIAL BOARD

Theresa Allio, PhD, RAC
Bayer Pharmaceuticals, New York City Area, NY, USA

Josephine Babiarz, JD
Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA

David R. Bristol, PhD
Statistical Consulting Services LLC, Winston Salem, NC, USA

Joseph C. Cappelleri, PhD, MPH, MS
Pfizer Inc., New York, NY, USA

Joseph A. DiMasi, PhD
Tufts University, Boston, MA, USA

Todd A. Durham, PhD
Novan, Inc., Durham, NC, USA

Alan M. Hochberg, BS
F. Hoffmann-La Roche Ltd, Basel, Switzerland

Wendy Lipworth, MBBS, PhD
The University of Sydney, Sydney, NSW, Australia

Shunsuke Ono, PhD
The University of Tokyo,Tokyo, Japan

Peter J. Pitts, BA
Adherent Health, LLC; Center for Medicine in the Public Interest, New York, NY, USA

Ronald J. Portman, MD
Novartis Pharmaceutical Corporation, East Hartford, CT, USA

Ramses F. Sadek, PhD
Augusta University, Augusta, GA, USA